CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06151197
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-14T00:03:53.392183+00:00
Published At: 2026-07-13T00:00:00+00:00
Record Updated At: 2026-07-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Plantar Fibromatosis", "Ledderhose Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-13"
protocolSection.identificationModule.nctId: "NCT06151197"
protocolSection.identificationModule.officialTitle: "A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis (PFI) (Also Known as Ledderhose Disease)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.